3,569
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

The outcome of patients with surgically treated meningioma in England: 1999–2013. A cancer registry data analysis

, , , , &
Pages 641-647 | Received 22 Apr 2019, Accepted 27 Aug 2019, Published online: 17 Sep 2019

References

  • Louis DN, Ohgaki H, Wiestler OD. ed. 2016. WHO classification of tumours of the centre nervous system revised. 4th ed. Lyon: IARC.
  • Ostrom QT, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro Oncol 2018;20:2018.
  • Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 2015;122:4–23.
  • Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 2016;17:e383–e391.
  • Schaffar R, Rachet B, Belot A, et al. Estimation of net survival for cancer patients: relative survival setting more robust to some assumption violations that cause specific setting, a sensitivity analysis on empirical data. Eur J Cancer 2017;72:78–83.
  • Williams M, Treasure P, Greenberg D, et al. Surgeon volume and 30 day mortality for brain tumours in England. Br J Cancer 2016;115:1379–82.
  • Cea-Soriano L, Wallander M-A, García Rodríguez LA, et al. Epidemiology of meningioma in the United Kingdom. Neuroepidemiology 2012;39:27–34.
  • Benson VS, Pirie K, Green J, et al. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 2008;99:185–90.
  • Wiemels J, Wrensch M, Claus EB, et al. Epidemiology and etiology of meningioma. J Neurooncol 2010;99:307–14.
  • Kleihues P, Cavenee WK. ed. 2000. Pathology and genetics of tumours of the nervous system. Lyon: IARC.
  • Louis DN, Ohgaki H, Wiestler OD. ed, 2007. WHO classification of tumours of the centre nervous system. 4th ed. Lyon: IARC.
  • Pearson BE, Markert JM, Fisher WS, et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus 2008;24:E3.
  • Connolly ID, Cole T, Veeravagu A, et al. Craniotomy for resection of meningioma: an age-stratified analysis of the MarketScan longitudinal database. World Neurosurg 2015;84:1864–70.
  • Poon MT-C, Fung LH-K, Pu JK-S, et al. Outcome of elderly patients undergoing intracranial meningioma resection–a systematic review and meta-analysis. Br J Neurosurg 2014;28:303–9.
  • Aizer AA, Bi WL, Kandola MS, et al. Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 2015;121:4376–81.
  • Savardekar AR, Patra DP, Bir S, et al. Differential tumor progression patterns in skull base versus non-skull base meningiomas: a critical analysis from a long-term follow-up study and review of literature. World Neurosurg 2018;112:e74–e83.
  • Benz LS, Wrensch MR, Schildkraut JM, et al. Quality of life after surgery for intracranial meningioma. Cancer 2017;124:161–6.
  • Nassiri F, et al. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life. Neuro Oncol 2019;14:i32–i43.
  • Ohba S, Kobayashi M, Horiguchi T, et al. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas. J Neurosurg 2011;114:1278–87.
  • Mansouri A, Klironomos G, Taslimi S, et al. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas. J Neurosurg 2016;125:431–40.
  • Sayagués JM, Tabernero MD, Maíllo A, et al. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J Neuropathol Exp Neurol 2006;65:445–54.
  • Klekamp J, Samii M. Surgical results for spinal meningiomas. Surg Neurol 1999;52:552–62.
  • Jenkinson MD, Simpson C, Nicholas RS, et al. Outcome predictors and complications in the management of intradural spinal tumours. Eur Spine J 2006;15:203–10.
  • Ravindra VM, Schmidt MH. Management of spinal meningiomas. Neurosurg Clin N Am 2016;27:195–205.
  • Nakamura M, Tsuji O, Fujiyoshi K, et al. Long-term surgical outcomes of spinal meningiomas. Spine 2012;37:E617–e623.
  • Ambekar S, Sharma M, Kukreja S, et al. Complications and outcomes of surgery for spinal meningioma: a Nationwide Inpatient Sample analysis from 2003 to 2010. Clin Neurol Neurosurg 2014;118:65–68.
  • Lekanne Deprez RH, Bianchi AB, Groen NA, et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994;54:1022–9.
  • Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Genome Res 2001;93:207–20.
  • Jansen M, Mohapatra G, Betensky RA, et al. Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Neuropathol Appl Neurobiol 2012;38:213–9.
  • Domingues P, González-Tablas M, Otero Á, et al. Genetic/molecular alterations of meningiomas and the signaling pathways targeted. Oncotarget 2015;6:10671–88.
  • Jacoby LB, Pulaski K, Rouleau GA, et al. Clonal analysis of human meningiomas and schwannomas. Cancer Res 1990;50:6783–6.
  • Bethke L, Murray A, Webb E, et al. Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 2008;100:270–6.
  • Sahm F, Schrimpf D, Stichel D, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 2017;18:682–94.
  • Suppiah S, Nassiri F, Bi WL, et al. Molecular and translational advances in meningiomas. Neuro-oncol 2019;21:i4–i17.